Novel benzothiazolone derivatives

Details for Australian Patent Application No. 2006277074 (hide)

Owner AstraZeneca AB

Inventors Bonnert, Roger; Flaherty, Alice; Pairaudeau, Garry; Stocks, Michael

Agent Freehills

Pub. Number AU-B-2006277074

PCT Pub. Number WO2007/018461

Priority 0501793-4 09.08.05 SE; 0501914-6 30.08.05 SE; 0600515-1 08.03.06 SE

Filing date 3 August 2006

Wipo publication date 15 February 2007

Acceptance publication date 4 March 2010

International Classifications

C07D 277/68 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/4439 (2006.01)

A61K 31/454 (2006.01)

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/018461 Priority application(s): WO2007/018461

4 March 2010 Application Accepted

  Published as AU-B-2006277074

1 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006277076-Interaction of Moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system

2006277069-A lock and key system with improved tumblers in the lock